CarolynSWuMD
Ophthalmology • Boston, MAPediatric & Strabismus
Instructor in Ophthalmology, Boston Children's Hospital
Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-6401Fax+1 617-730-0392
Education & Training
NYU Grossman School of MedicineResidency, Ophthalmology, 2000 - 2003
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 1999 - 2000
Albert Einstein College of MedicineClass of 1999
Certifications & Licensure
NH State Medical License 2020 - 2026
MA State Medical License 2003 - 2025
NY State Medical License 2001 - 2025
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP Start of enrollment: 2022 Apr 27
Roles: Contact
- Bevacizumab Treatment For Type 1 ROP Start of enrollment: 2022 May 18
Roles: Contact
Publications & Presentations
PubMed
- Evaluating the Utility of Initial Examinations in Retinopathy of Prematurity: Proposal of FIRST-ROP Algorithm for a Medium-Risk Cohort.Francisco Altamirano, Melissa Yuan, Sandra Hoyek, Daniel Hu, Muhammad Abidi
Ophthalmology. 2025-01-08 - 2 citationsValidation of the "TWO-ROP" Algorithm at a Multi-Neonatal Intensive Care Unit Tertiary Referral Center.Nimesh A Patel, Francisco Altamirano, Sandra Hoyek, Hanna De Bruyn, Anne Fulton
Ophthalmology. Retina. 2025-01-01 - 3 citationsElectroretinographic Responses in Retinopathy of Prematurity Treated Using Intravitreal Bevacizumab or Laser.Amber-Lee K Curran, Justyna Stukin, Lucia Ambrosio, Iason S Mantagos, Carolyn Wu
American Journal of Ophthalmology. 2023-08-01
Press Mentions
Pioneering Trial Offers Hope for Late Treatment of ‘Lazy Eye’September 2nd, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
